SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001037389-20-000083
Filing Date
2020-02-12
Accepted
2020-02-12 15:57:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 cldx-13g_20191231.txt SC 13G 11757
  Complete submission text file 0001037389-20-000083.txt   13529
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Subject) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-37761 | Film No.: 20603935
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 800 THIRD AVE NEW YORK NY 10022
Business Address 800 THIRD AVE NEW YORK NY 10022 2124866780
RENAISSANCE TECHNOLOGIES LLC (Filed by) CIK: 0001037389 (see all company filings)

IRS No.: 260385758 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G